Sustained Relief of Central Pain after Stroke with Stereotactic Thalamotomy: A Case Secondary to Aneurysm Embolization.
WSSFN 2025 Interim Meeting. Abstract 0126
DOI:
https://doi.org/10.47924/neurotarget2025565Resumen
Introduction:Central neuropathic pain is a debilitating condition resulting from lesions in the central nervous system, such as strokes, trauma, or neurovascular procedures. Its management represents a major clinical challenge, as it often does not respond to conventional pharmacological treatment. In refractory cases, functional surgical interventions, such as stereotactic thalamotomy, have been used with promising results, providing symptomatic relief and improvement in quality of life¹⁻³.
Method:Male, 55 years old, with a history of chronic headache since childhood, presented with progressive worsening over the past six months, accompanied by vomiting. Neurological examination revealed anisocoria with reactive pupils and mild left-sided dysmetria. CT angiography showed an aneurysm of the left anterior inferior cerebellar artery (AICA). Endovascular embolization of an arteriovenous fistula and the aneurysm with liquid embolic material was performed, achieving good pedicle occlusion. After the procedure, imaging demonstrated interruption of flow in the left AICA, resulting in an ischemic stroke, with left peripheral facial paralysis, painful dysesthesia in the right hemibody (face, arm, and leg), and gait ataxia. Pain was partially controlled with Gabapentin and Carbamazepine. Due to refractoriness, stereotactic thalamotomy targeting the left Centromedian (CM) and Ventral posterolateral (VPL) thalamic nuclei was performed without complications. Initially, pain persisted, but the patient was informed about the possibility of delayed response. Over time, Duloxetine was introduced, leading to progressive improvement. After one year, there was significant relief of neuropathic pain. The patient currently remains on Gabapentin and Duloxetine, with occasional headaches and marked improvement in quality of life.
Discussion:The management of central neuropathic pain requires an individualized approach. Many patients are refractory to standard pharmacological therapy². In such cases, functional neurosurgery, such as stereotactic thalamotomy targeting the CM and VPL nuclei, may be an effective alternative. Recent studies have shown favorable outcomes, with a low complication rate and sustained response¹,³.
Conclusions:In cases of refractory central neuropathic pain, stereotactic thalamotomy represents a viable option. Continuous follow-up and personalized treatment are essential to improve clinical outcomes and quality of life.
Métricas
Citas
Raslan AM, McCartney S, Burchiel KJ. Management of central post-stroke pain: the role of motor cortex stimulation and other therapies. Neurol Res. 2022;44(1):5–12. doi:10.1080/01616412.2021.1943700
Attal N, Bouhassira D, Baron R. Diagnosis and assessment of neuropathic pain through questionnaires. Lancet Neurol. 2023;22(4):314–326. doi:10.1016/S1474-4422(23)00040-2
Kim YH, Lee JY, Kim J, et al. Long-term outcomes of stereotactic thalamotomy for central pain syndrome. Stereotact Funct Neurosurg. 2023;101(2):89–97. doi:10.1159/000530088
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2025 Isis Franco Martin, Igor Bagini Mateus, Henrique Aguiar Lima, Rafael Leão De Moraes, Emanuele Pires Canela Dos Santos, Bruna Dias Rocha, Paulo Luiz Da Costa Cruz, Paulo Niemeyer Soares Filho

Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Este artículo se distribuye bajo la licencia Creative Commons Attribution 4.0 License. A menos que se indique lo contrario, el material publicado asociado se distribuye bajo la misma licencia.
